U.S. market Closed. Opens in 3 hours 46 minutes

HQL | Tekla Life Sciences Investors Stock Overview

(Stock Exchange: NYSE)
Day's Range 14.62 - 14.78
52 Week Range 11.62 - 15.90
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 35,449
Average Volume 67,735
Shares Outstanding 27,350,500
Market Cap 402,325,855
Sector Financial Services
Industry Asset Management
IPO Date 1992-05-01
Valuation
Profitability
Growth
Health
P/E Ratio 10.98
Forward P/E Ratio N/A
EPS 1.34
1YR Price Target N/A
Dividend Yield 13.46%
Dividend Per Share 1.98
Dividend ExDate N/A
Dividend PayDate N/A
Employees 0
Country USA
Website HQL
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
HQL's peers: BTO, DFP, DPG, EMF, HQH, THW, THQ, RVT, UTF, ETG, MYD, EVT, ETB, NXC, RNP, XFLT, JPI, FPF, FFC, ETJ, NDP, TDF
*Chart delayed
Analyzing fundamentals for HQL we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see HQL Fundamentals page.

Watching at HQL technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on HQL Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙